Dr A. Dermesropian
0762.847.392 · rovalta.com · 24/09/2026
Dr A. Dermesropian
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBODr A. Dermesropian is a Private limited company incorporated in 2021. Its registered office is in Woluwe-Saint-Lambert.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0762.847.392
- Incorporation
- 03/02/2021
- Legal form
- Private limited company
- Registered office
- Avenue du Mistral 82/b9
1200 Woluwe-Saint-Lambert · BruxellesSee on map - Contributed capital
- 3 000,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 5 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 160,2 k € | -17.7% | 194,7 k € | -7.8% | 211,1 k € | +38.2% | 152,7 k € | +61.1% | 94,8 k € |
| EBITDA | 159,4 k € | -17.8% | 194 k € | -7.8% | 210,4 k € | +38.3% | 152,1 k € | +61.0% | 94,5 k € |
| Operating result | 159 k € | -17.8% | 193,6 k € | -7.8% | 209,9 k € | +38.6% | 151,5 k € | +61.0% | 94,1 k € |
| Net result | 122,9 k € | -18.4% | 150,6 k € | -4.5% | 157,7 k € | +39.3% | 113,2 k € | +50.4% | 75,3 k € |
| Balance sheet | |||||||||
| Equity | 3 k € | -99.4% | 499,8 k € | +43.1% | 349,2 k € | +82.4% | 191,5 k € | +145% | 78,3 k € |
| Total assets | 132,4 k € | -73.8% | 505,8 k € | +44.0% | 351,3 k € | +76.6% | 198,9 k € | +119% | 91 k € |
| Cash | 69,7 k € | -42.4% | 121,1 k € | -65.3% | 349,5 k € | +95.9% | 178,4 k € | +189% | 61,7 k € |
| Debts | 129,4 k € | +2069% | 6 k € | +178% | 2,1 k € | -71.3% | 7,5 k € | -41.5% | 12,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 03/02/2021 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 11 months |
| Filing date | 19/05/2026 | 16/07/2025 | 29/07/2024 | 31/07/2023 | 27/07/2022 |
| General meeting | 24/04/2026 | 20/06/2025 | 28/06/2024 | 30/06/2023 | 24/06/2022 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 5 filingsValuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active
Active mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other05/02/2021RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025122,9 k €↓
- 2024Annual accounts 2024150,6 k €↓
- 2023Annual accounts 2023157,7 k €↑
- 2022Annual accounts 2022113,2 k €↑
- 2021Annual accounts 202175,3 k €
- 03/02/2021IncorporationPrivate limited company